Organon & Co. (OGN)

USD 11.52

(2.45%)

Gross Profit Summary of Organon & Co.

  • Organon & Co.'s latest annual gross profit in 2023 was 3.74 Billion USD , down -3.4% from previous year.
  • Organon & Co.'s latest quarterly gross profit in 2024 Q1 was 957 Million USD , up 4.59% from previous quarter.
  • Organon & Co. reported a annual gross profit of 3.88 Billion USD in annual gross profit 2022, down -1.07% from previous year.
  • Organon & Co. reported a annual gross profit of 3.92 Billion USD in annual gross profit 2021, down -17.41% from previous year.
  • Organon & Co. reported a quarterly gross profit of 939 Million USD for 2024 Q2, down -1.88% from previous quarter.
  • Organon & Co. reported a quarterly gross profit of 957 Million USD for 2024 Q1, up 4.59% from previous quarter.

Annual Gross Profit Chart of Organon & Co. (2023 - 2017)

Historical Annual Gross Profit of Organon & Co. (2023 - 2017)

Year Gross Profit Gross Profit Growth
2023 3.74 Billion USD -3.4%
2022 3.88 Billion USD -1.07%
2021 3.92 Billion USD -17.41%
2020 4.74 Billion USD -13.7%
2019 5.5 Billion USD 8.24%
2018 5.08 Billion USD -14.01%
2017 5.91 Billion USD 0.0%

Peer Gross Profit Comparison of Organon & Co.

Name Gross Profit Gross Profit Difference
AbbVie Inc. 45.53 Billion USD 91.77%
Bristol-Myers Squibb Company 34.31 Billion USD 89.077%
Bristol-Myers Squibb Company Ce 34.31 Billion USD 89.077%
Johnson & Johnson 58.6 Billion USD 93.605%
Eli Lilly and Company 27.04 Billion USD 86.14%
Merck & Co., Inc. 43.98 Billion USD 91.48%
Novartis AG 34.18 Billion USD 89.037%
Pfizer Inc. 28.8 Billion USD 86.99%